scispace - formally typeset
M

Meera Gupta

Researcher at University of Kentucky

Publications -  49
Citations -  1208

Meera Gupta is an academic researcher from University of Kentucky. The author has contributed to research in topics: Transplantation & Medicine. The author has an hindex of 19, co-authored 40 publications receiving 1004 citations. Previous affiliations of Meera Gupta include Children's Hospital of Philadelphia & Hospital of the University of Pennsylvania.

Papers
More filters
Journal ArticleDOI

Cost-effectiveness of Competing Strategies for Management of Recurrent Clostridium difficile Infection: A Decision Analysis

TL;DR: It is demonstrated that FMT colonoscopy is the most cost-effective initial strategy for management of recurrent CDI, and in clinical settings where FMT is not available or applicable, the preferred strategy appears to be initial treatment with oral vancomycin.
Journal ArticleDOI

Outcomes after resection of leiomyosarcomas of the inferior vena cava: A pooled data analysis of 377 cases

TL;DR: Following resection of IVC leiomyosarcomas, recurrence is a near certainty; long-term survival, however is possible; the dominant predictors of survival include margin status, tumor size and radical resection.
Journal ArticleDOI

Alveolar macrophages contribute to the pathogenesis of human metapneumovirus infection while protecting against respiratory syncytial virus infection.

TL;DR: It is demonstrated that AMs have distinct roles in the context of human infections caused by members of the Paramyxoviridae family, and lack of AMs resulted in a broad-spectrum disruption in type I IFN and certain inflammatory cytokine production, while causing a virus-specific alteration in the profile of several immunomodulatory cytokines, chemokines, and growth factors.
Journal ArticleDOI

Effect of etiology and timing of respiratory tract infections on development of bronchiolitis obliterans syndrome.

TL;DR: P pneumonias with GP, GN and fungal pathogens occurring prior to BOS are independent determinants of chronic allograft dysfunction and early recognition and treatment of these pathogens in lung transplant recipients may improve long-term outcomes after transplantation.